Exclusive Global License Agreement with Zoetis
Filed with ASX · · 2 pages · English
Anatara Lifesciences Ltd on 6ix
In the deck
Story so far
Earlier from Anatara Lifesciences
- FDA approves the Human Food Safety Dossier
- R&D Tax Incentive Received
- Pork CRC Options extended by 12 Months
- Preliminary Final Report
- ANR and Zoetis to negotiate International Detach Commercial
Later from Anatara Lifesciences
- Anatara CEO announces retirement
- Investor Presentation and Strategy Update
- Appendix 4E & Audited Financial Statements
- APVMA approval for Detach
- Chief Executive Officer Appointment
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences